Study of Certain Prevail Implants Used to Treat All Types of Edentulism in the Maxilla and Mandible (PrevailMulti)
Observational Study of Certain Prevail Implant System in Maxillary and Mandibular Regions
Sponsor: ZimVie
A observational or N/A phase clinical study on Partial Edentulism, this trial is completed. The trial is conducted by ZimVie and has accumulated 15 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2024 — Jul 2024 [monthly]
Completed
-
Sep 2022 — Feb 2024 [monthly]
Completed
-
Apr 2022 — Sep 2022 [monthly]
Completed
▶ Show 10 earlier versions
-
Jun 2021 — Apr 2022 [monthly]
Completed
-
Feb 2021 — Jun 2021 [monthly]
Completed
-
Jan 2021 — Feb 2021 [monthly]
Completed
-
Sep 2020 — Jan 2021 [monthly]
Completed
-
Jun 2019 — Sep 2020 [monthly]
Completed
-
Jan 2019 — Jun 2019 [monthly]
Completed
-
Jun 2018 — Jan 2019 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Oct 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ZimVie
For direct contact, visit the study record on ClinicalTrials.gov .